We are Sorry, This Page doesn't Exist
Biogen Inks Two Deals to Make Drugs for Neurological Diseases
Biogen (BIIB) signs deals with C4 Therapeutics and Skyhawk Therapeutics to develop potential therapies for Alzheimer's disease (AD), Parki.....»»
Atrium Health Wake Forest Baptist treats first local patient with FDA-approved Alzheimer’s disease drug
On March 14, 2024, Atrium Health Wake Forest Baptist became the first health system in the region to treat a patient with lecanemab, a new medication for Alzheimer’s disease. This is the first Alzheimer’s drug approved by the FDA in more than 20 .....»»
AnPac Bio approves joint venture to develop new cancer treatment technology
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
Rolling NDA submission for CUTX-101 for the treatment of Menkes disease is expected to begin in the second half of 2021 On track to report top-line results from the registration-enabling study of cosibelimab in metastatic cutaneous squ.....»»
Swedish biopharmaceutical firm Intrance establishes U.S. operations in Philadelphia region
The company was formed to bring a treatment for patients with advanced Parkinson's disease to the United States......»»
Eli Lilly CEO David Ricks On Alzheimer’s Disease Drugs
CNBC transcript: Eli Lilly And Co (NYSE:LLY) Chairman & CEO David Ric.....»»
Cassava Sciences initiates cognition maintenance study on Alzheimer"s disease
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ChemoCentryx"s stock dives after critique from the FDA about experimental treatment for rare autoimmune disease
Shares of ChemoCentryx Inc. plunged 44.8% in trading on Tuesday after the Food and Drug Administration questioned the rat.....»»
Alimera Science"s Innovative Treatment for Diabetic Macular Edema Vision Loss Lasts for up to 3 Years
Intravitreal Implant Provides a Daily Microdose Release to Reduce Disease Recurrence read more.....»»
Vertex to study experimental gene-editing therapy as treatment for sickle cell, beta-thalassemia
Vertex Pharmaceuticals Inc. said Tuesday it plans to pay $1.1 billion to Crispr Therapeutics AG as part of a deal to test an experimental gene-editing therapy for sickle cell disease and transfusion-dependent beta-tha.....»»
Scientists are reaching a new understanding about Alzheimer"s disease
These are Insid.....»»
Lilly"s stock is down after sharing additional clinical data about its Alzheimer"s disease drug candidate
ShaShares of Eli Lilly & Co. were down 5.2% in premarket trading on Monday, two days after the drug maker said additional clinical-trial data reinforced the role its experi.....»»
Eli Lilly falls 9% after its Alzheimer"s drug data underwhelms Wall Street
A successful Alzheimer's drug has been viewed as the holy grail in biotech, as it would combat a devastating disease that has a large unmet need. The logo of Lilly is seen on a wall of the Lilly France co.....»»
Gilead, Merck to develop long-acting HIV therapy treatment, WSJ reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eisai presents updated results of lecanemab study in early Alzheimer"s disease
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Caladrius treatment of Buerger"s disease granted FDA orphan designation
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
This giant 1950s town replica in California is a new kind of treatment center for people with Alzheimer"s
Glenner Town Square looks l.....»»
Hoth files provisional patent application with USPTO for Alzheimer"s treatment
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bluebird Bio shares slide 34% after company suspends trials of sickle cell disease treatment
Shares of Bluebird Bio Inc. slid 34% in premarket trade Tuesday, after the biotech said it is temporarily suspending Phase 1/2 and Phase 3 trials of .....»»